Ardelyx, Inc.
US ˙ NasdaqGM ˙ US0396971071

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Presidio Partners 2007 (Parallel), L.P.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Presidio Partners 2007 (Parallel), L.P. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:VYNE / VYNE Therapeutics Inc. 48.910
10% Owner 39.998
US:ARDX / Ardelyx, Inc. 10% Owner 63.490
US:ASPX / Auspex Pharmaceuticals, Inc. 10% Owner 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Presidio Partners 2007 (Parallel), L.P.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb ARDX / Ardelyx, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ARDX / Ardelyx, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-06-24 ARDX Presidio Partners 2007, L.P. 308.905 14,0000 308.905 14,0000 4.324.670 162 32.89 5.835.215 134,93
2014-06-24 ARDX Presidio Partners 2007, L.P. 7.921 14,0000 7.921 14,0000 110.894

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ARDX / Ardelyx, Inc. Insider Trades
Insidersalg ARDX / Ardelyx, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ARDX / Ardelyx, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2015-01-30 ARDX Presidio Partners 2007, L.P. 165.750 27,3700 165.750 27,3700 4.536.578 96 8.32 -3.157.537 -69,60
2015-01-30 ARDX Presidio Partners 2007, L.P. 4.250 27,3700 4.250 27,3700 116.322
2015-01-08 ARDX Presidio Partners 2007, L.P. 292.500 24,2500 292.500 24,2500 7.093.125
2015-01-08 ARDX Presidio Partners 2007, L.P. 7.500 24,2500 7.500 24,2500 181.875

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ARDX / Ardelyx, Inc. Insider Trades
Insiderkøb VYNE / VYNE Therapeutics Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ARDX / Ardelyx, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VYNE / VYNE Therapeutics Inc. Insider Trades
Insidersalg VYNE / VYNE Therapeutics Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ARDX / Ardelyx, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2018-07-24 MNLO Presidio Partners 2007 GP, L.P. 487.500 7,6500 44.318 84,1500 3.729.375 156 3.7900 -3.561.410 -95,50
2018-07-24 MNLO Presidio Partners 2007 GP, L.P. 12.500 7,6500 1.136 84,1500 95.625

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VYNE / VYNE Therapeutics Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Presidio Partners 2007 (Parallel), L.P. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2018-07-26 2018-07-24 4 MNLO Menlo Therapeutics Inc.
Common Stock
S - Sale -12.500 48.910 -20,35 7,65 -95.625 374.162
2018-07-26 2018-07-24 4 MNLO Menlo Therapeutics Inc.
Common Stock
S - Sale -487.500 1.907.568 -20,35 7,65 -3.729.375 14.592.895
2018-07-26 2018-03-02 4 MNLO Menlo Therapeutics Inc.
Common Stock
J - Other 152.062 152.062
2018-01-29 2018-01-29 4 MNLO Menlo Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -21.789 0 -100,00
2018-01-29 2018-01-29 4 MNLO Menlo Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -343.310 0 -100,00
2018-01-29 2018-01-29 4 MNLO Menlo Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -58.777 0 -100,00
2018-01-29 2018-01-29 4 MNLO Menlo Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -2.292.320 0 -100,00
2018-01-29 2018-01-29 4 MNLO Menlo Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -179 0 -100,00
2018-01-29 2018-01-29 4 MNLO Menlo Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -6.971 0 -100,00
2018-01-29 2018-01-29 4 MNLO Menlo Therapeutics, Inc.
Common Stock
C - Conversion 3.263 61.410 5,61
2018-01-29 2018-01-29 4 MNLO Menlo Therapeutics, Inc.
Common Stock
C - Conversion 127.269 2.395.068 5,61
2018-01-29 2018-01-29 4 MNLO Menlo Therapeutics, Inc.
Common Stock
C - Conversion 21.789 58.147 59,93
2018-01-29 2018-01-29 4 MNLO Menlo Therapeutics, Inc.
Common Stock
C - Conversion 849.794 2.267.799 59,93
2018-01-29 2018-01-29 4 MNLO Menlo Therapeutics, Inc.
Common Stock
C - Conversion 66 36.358 0,18
2018-01-29 2018-01-29 4 MNLO Menlo Therapeutics, Inc.
Common Stock
C - Conversion 2.584 1.418.005 0,18
2018-01-24 3 MNLO Menlo Therapeutics, Inc.
Common Stock
2.867.134
2018-01-24 3 MNLO Menlo Therapeutics, Inc.
Common Stock
1.488.005
2018-01-24 3 MNLO Menlo Therapeutics, Inc.
Common Stock
2.867.134
2018-01-24 3 MNLO Menlo Therapeutics, Inc.
Common Stock
1.488.005
2018-01-24 3 MNLO Menlo Therapeutics, Inc.
Common Stock
2.867.134
2018-01-24 3 MNLO Menlo Therapeutics, Inc.
Common Stock
1.488.005
2018-01-24 3 MNLO Menlo Therapeutics, Inc.
Common Stock
2.867.134
2018-01-24 3 MNLO Menlo Therapeutics, Inc.
Common Stock
1.488.005
2018-01-24 3 MNLO Menlo Therapeutics, Inc.
Common Stock
2.867.134
2018-01-24 3 MNLO Menlo Therapeutics, Inc.
Common Stock
1.488.005
2018-01-24 3 MNLO Menlo Therapeutics, Inc.
Common Stock
2.867.134
2018-01-24 3 MNLO Menlo Therapeutics, Inc.
Common Stock
1.488.005
2018-01-24 3 MNLO Menlo Therapeutics, Inc.
Common Stock
2.867.134
2018-01-24 3 MNLO Menlo Therapeutics, Inc.
Common Stock
1.488.005
2016-04-20 2016-04-20 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -213 39.998 -0,53 9,88 -2.105 395.344
2016-04-20 2016-04-20 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -8.327 1.559.995 -0,53 9,88 -82.305 15.419.147
2016-04-20 2016-04-19 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -182 40.211 -0,45 10,03 -1.825 403.276
2016-04-20 2016-04-19 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -7.097 1.568.322 -0,45 10,03 -71.176 15.728.701
2016-04-20 2016-04-18 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -114 40.393 -0,28 10,10 -1.151 407.953
2016-04-20 2016-04-18 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -4.434 1.575.419 -0,28 10,10 -44.782 15.911.102
2016-04-15 2016-04-15 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -180 40.507 -0,44 10,32 -1.857 417.935
2016-04-15 2016-04-15 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -275 40.687 -0,67 10,13 -2.785 411.976
2016-04-15 2016-04-15 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -7.020 1.579.853 -0,44 10,32 -72.430 16.300.291
2016-04-15 2016-04-15 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -10.735 1.586.873 -0,67 10,13 -108.697 16.067.883
2016-04-15 2016-04-14 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -325 40.962 -0,79 10,32 -3.353 422.654
2016-04-15 2016-04-14 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -352 41.287 -0,85 10,27 -3.614 423.873
2016-04-15 2016-04-14 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -12.675 1.597.608 -0,79 10,32 -130.783 16.484.439
2016-04-15 2016-04-14 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -13.714 1.610.283 -0,84 10,27 -140.795 16.531.970
2016-04-15 2016-04-13 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -317 41.639 -0,76 10,16 -3.221 423.131
2016-04-15 2016-04-13 4 NEOS Neos Therapeutics, Inc.
Common Stock
S - Sale -12.375 1.623.997 -0,76 10,16 -125.754 16.502.895
2015-12-17 2015-12-15 4 ARDX ARDELYX, INC.
Common Stock
J - Other -7.500 63.490 -10,56
2015-12-17 2015-12-15 4 ARDX ARDELYX, INC.
Common Stock
J - Other -292.500 2.476.216 -10,56
2015-07-28 2015-07-28 4 NEOS Neos Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -10.000 0 -100,00
2015-07-28 2015-07-28 4 NEOS Neos Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -41.700 0 -100,00
2015-07-28 2015-07-28 4 NEOS Neos Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -25.000 0 -100,00
2015-07-28 2015-07-28 4 NEOS Neos Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -390.000 0 -100,00
2015-07-28 2015-07-28 4 NEOS Neos Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -1.626.294 0 -100,00
2015-07-28 2015-07-28 4 NEOS Neos Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -975.000 0 -100,00
2015-07-28 2015-07-28 4 NEOS Neos Therapeutics, Inc.
Common Stock
C - Conversion 4.166 1.278.328 0,33
2015-07-28 2015-07-28 4 NEOS Neos Therapeutics, Inc.
Common Stock
C - Conversion 17.374 1.274.162 1,38
2015-07-28 2015-07-28 4 NEOS Neos Therapeutics, Inc.
Common Stock
C - Conversion 10.416 1.256.788 0,84
2015-07-28 2015-07-28 4 NEOS Neos Therapeutics, Inc.
Common Stock
C - Conversion 162.500 1.246.372 14,99
2015-07-28 2015-07-28 4 NEOS Neos Therapeutics, Inc.
Common Stock
C - Conversion 677.622 1.083.872 166,80
2015-07-28 2015-07-28 4 NEOS Neos Therapeutics, Inc.
Common Stock
C - Conversion 406.250 406.250
2015-07-28 2015-07-27 4 NEOS Neos Therapeutics, Inc.
Preferred Stock Warrant (Right to Buy)
X - Other -10.000 0 -100,00
2015-07-28 2015-07-27 4 NEOS Neos Therapeutics, Inc.
Preferred Stock Warrant (Right to Buy)
X - Other -390.000 0 -100,00
2015-04-10 2015-04-08 4 ARDX ARDELYX, INC.
Common Stock
J - Other -10.000 70.990 -12,35
2015-04-10 2015-04-08 4 ARDX ARDELYX, INC.
Common Stock
J - Other -390.000 2.768.716 -12,35
2015-04-06 2015-04-02 4 ASPX Auspex Pharmaceuticals, Inc.
Put option (right to sell)
J - Other -1 0 -100,00
2015-04-06 2015-04-02 4 ASPX Auspex Pharmaceuticals, Inc.
Put option (right to sell
J - Other -1 0 -100,00
2015-04-06 2015-04-02 4 ASPX Auspex Pharmaceuticals, Inc.
Call Option (obligation to sell)
X - Other -1 0 -100,00
2015-04-06 2015-04-02 4 ASPX Auspex Pharmaceuticals, Inc.
Call Option (obligation to sell
X - Other -1 0 -100,00
2015-04-06 2015-04-02 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
X - Other -7.500 63.589 -10,55 29,79 -223.425 1.894.316
2015-04-06 2015-04-02 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
X - Other -292.500 2.478.021 -10,56 29,79 -8.713.575 73.820.246
2015-02-26 2015-02-24 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
J - Other -5.000 71.089 -6,57
2015-02-26 2015-02-24 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
J - Other -195.000 2.770.521 -6,58
2015-02-17 2015-02-13 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -1.047 76.089 -1,36 62,98 -65.943 4.792.313
2015-02-17 2015-02-13 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -40.786 2.965.521 -1,36 62,98 -2.568.825 186.777.409
2015-02-17 2015-02-12 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -325 77.136 -0,42 64,00 -20.800 4.936.704
2015-02-17 2015-02-12 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -1.696 77.461 -2,14 62,96 -106.782 4.877.038
2015-02-17 2015-02-12 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -12.675 3.006.307 -0,42 64,00 -811.200 192.403.648
2015-02-17 2015-02-12 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -66.138 3.018.982 -2,14 62,96 -4.164.128 190.078.729
2015-02-17 2015-01-08 4 ASPX Auspex Pharmaceuticals, Inc.
Warrant (right to buy))
X - Other -1.058 0 -100,00
2015-02-17 2015-01-08 4 ASPX Auspex Pharmaceuticals, Inc.
Warrant (right to buy)
X - Other -41.282 0 -100,00
2015-02-17 2015-01-08 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -84 83.589 -0,10 49,13 -4.127 4.106.644
2015-02-17 2015-01-08 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
X - Other 1.058 83.673 1,28 3,88 4.104 324.568
2015-02-17 2015-01-08 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -3.260 3.258.021 -0,10 49,13 -160.161 160.063.314
2015-02-17 2015-01-08 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
X - Other 41.282 3.261.281 1,28 3,88 160.133 12.650.509
2015-02-17 2015-02-11 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -1.327 79.157 -1,65 61,84 -82.062 4.895.069
2015-02-17 2015-02-11 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -51.773 3.085.120 -1,65 61,84 -3.201.642 190.783.821
2015-02-17 2015-02-10 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -20.670 3.136.893 -0,65 60,05 -1.241.234 188.370.425
2015-02-11 2015-02-11 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -1.327 79.157 -1,65 61,84 -82.062 4.895.069
2015-02-11 2015-02-11 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -51.773 3.112.120 -1,64 61,84 -3.201.642 192.453.501
2015-02-11 2015-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -530 80.484 -0,65 60,05 -31.826 4.833.064
2015-02-11 2015-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -20.670 3.163.893 -0,65 60,05 -1.241.234 189.991.775
2015-02-11 2015-02-09 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -246 81.014 -0,30 59,00 -14.514 4.779.826
2015-02-11 2015-02-09 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -9.608 3.157.563 -0,30 59,00 -566.872 186.296.217
2015-02-06 2015-02-06 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -757 81.260 -0,92 59,48 -45.026 4.833.345
2015-02-06 2015-02-06 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -29.522 3.167.171 -0,92 59,48 -1.755.969 188.383.331
2015-02-06 2015-02-05 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -322 82.017 -0,39 59,51 -19.162 4.880.832
2015-02-06 2015-02-05 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -12.578 3.196.693 -0,39 59,51 -748.517 190.235.200
2015-02-06 2015-02-04 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -1.250 82.339 -1,50 59,30 -74.125 4.882.703
2015-02-06 2015-02-04 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -48.750 3.209.271 -1,50 59,30 -2.890.875 190.309.770
2015-02-03 2015-01-30 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -4.250 80.990 -4,99 27,37 -116.322 2.216.696
2015-02-03 2015-01-30 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -165.750 3.158.716 -4,99 27,37 -4.536.578 86.454.057
2015-01-12 2015-01-08 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -7.500 85.240 -8,09 24,25 -181.875 2.067.070
2015-01-12 2015-01-08 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -292.500 3.324.466 -8,09 24,25 -7.093.125 80.618.300
2015-01-02 2014-12-30 4 ARDX ARDELYX, INC.
Common Stock
J - Other -10.000 92.740 -9,73
2015-01-02 2014-12-30 4 ARDX ARDELYX, INC.
Common Stock
J - Other -390.000 3.616.966 -9,73
2014-12-22 2014-12-18 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
J - Other -7.625 82.615 -8,45
2014-12-22 2014-12-18 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
J - Other -297.375 3.219.999 -8,45
2014-12-22 2014-12-18 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -4.875 90.240 -5,13 50,14 -244.432 4.524.634
2014-12-22 2014-12-18 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -190.125 3.517.374 -5,13 50,14 -9.532.868 176.361.132
2014-12-01 2014-11-10 4/A ASPX Auspex Pharmaceuticals, Inc.
Call Option (right to buy)
S - Sale -1 1 -50,00 137.198,27 -137.198 137.198
2014-12-01 2014-11-10 4/A ASPX Auspex Pharmaceuticals, Inc.
Put Option (right to sell)
P - Purchase 1 1 137.198,27 137.198 137.198
2014-12-01 2014-11-10 4/A ASPX Auspex Pharmaceuticals, Inc.
Call Option (right to buy)
S - Sale -1 1 -50,00 137.198,27 -137.198 137.198
2014-12-01 2014-11-10 4/A ASPX Auspex Pharmaceuticals, Inc.
Put Option (right to sell)
P - Purchase 1 1 137.198,27 137.198 137.198
2014-11-12 2014-11-10 4 ASPX Auspex Pharmaceuticals, Inc.
Call Option (right to buy)
S - Sale -1 1 -50,00
2014-11-12 2014-11-10 4 ASPX Auspex Pharmaceuticals, Inc.
Call Option (right to buy)
S - Sale -1 1 -50,00
2014-11-12 2014-11-10 4 ASPX Auspex Pharmaceuticals, Inc.
Put Option (right to sell)
P - Purchase 1 1
2014-11-12 2014-11-10 4 ASPX Auspex Pharmaceuticals, Inc.
Put Option (right to sell)
P - Purchase 1 1
2014-10-31 2014-10-30 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -197 95.115 -0,21 27,33 -5.383 2.599.151
2014-10-31 2014-10-30 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -7.633 3.707.499 -0,21 27,33 -208.582 101.312.601
2014-10-31 2014-10-29 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -279 95.312 -0,29 27,02 -7.539 2.575.616
2014-10-31 2014-10-29 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -10.891 3.715.132 -0,29 27,02 -294.307 100.394.012
2014-10-29 2014-10-28 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -275 95.591 -0,29 26,99 -7.422 2.580.078
2014-10-29 2014-10-28 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -10.725 3.726.023 -0,29 26,99 -289.476 100.568.342
2014-10-29 2014-10-27 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -87 95.866 -0,09 27,11 -2.359 2.599.349
2014-10-29 2014-10-27 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -3.413 3.736.748 -0,09 27,11 -92.541 101.319.680
2014-10-27 2014-10-24 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -272 95.953 -0,28 27,09 -7.367 2.598.945
2014-10-27 2014-10-24 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -10.628 3.740.161 -0,28 27,09 -287.866 101.304.505
2014-10-27 2014-10-23 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -140 96.225 -0,15 26,74 -3.743 2.572.595
2014-10-27 2014-10-23 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -5.460 3.750.789 -0,15 26,74 -145.974 100.278.094
2014-10-15 2014-10-06 4/A ASPX Auspex Pharmaceuticals, Inc.
Warrant (right to buy))
X - Other -1.074 0 -100,00
2014-10-15 2014-10-06 4/A ASPX Auspex Pharmaceuticals, Inc.
Warrant (right to buy)
X - Other -41.892 0 -100,00
2014-10-15 2014-10-06 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -178 96.365 -0,18 23,44 -4.173 2.259.277
2014-10-15 2014-10-06 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
X - Other 1.074 96.543 1,12 3,88 4.166 374.490
2014-10-15 2014-10-06 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -6.931 3.756.249 -0,18 23,44 -162.497 88.065.258
2014-10-15 2014-10-06 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
X - Other 41.892 3.763.180 1,13 3,88 162.499 14.597.375
2014-10-08 2014-10-06 4 ASPX Auspex Pharmaceuticals, Inc.
Warrant (right to buy))
X - Other -1.074 0 -100,00
2014-10-08 2014-10-06 4 ASPX Auspex Pharmaceuticals, Inc.
Warrant (right to buy)
X - Other -41.892 0 -100,00
2014-10-08 2014-10-06 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -178 104.504 -0,17 23,44 -4.173 2.450.096
2014-10-08 2014-10-06 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
X - Other 1.074 104.682 1,04 3,88 4.166 406.061
2014-10-08 2014-10-06 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -6.931 3.781.210 -0,18 23,44 -162.497 88.650.468
2014-10-08 2014-10-06 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
X - Other 41.892 3.788.141 1,12 3,88 162.499 14.694.199
2014-09-30 2014-09-09 4/A ASPX Auspex Pharmaceuticals, Inc.
Call Option (obligation to sell)
S - Sale -1 1 -50,00 288.448,54 -288.449 288.449
2014-09-30 2014-09-09 4/A ASPX Auspex Pharmaceuticals, Inc.
Put Option (right to sell)
P - Purchase 1 1 288.448,54 288.449 288.449
2014-09-30 2014-09-09 4/A ASPX Auspex Pharmaceuticals, Inc.
Call Option (obligation to sell)
S - Sale -1 1 -50,00 288.448,54 -288.449 288.449
2014-09-30 2014-09-09 4/A ASPX Auspex Pharmaceuticals, Inc.
Put Option (right to sell)
P - Purchase 1 1 288.448,54 288.449 288.449
2014-09-11 2014-09-09 4 ASPX Auspex Pharmaceuticals, Inc.
Call Option (obligation to sell)
S - Sale 1 1
2014-09-11 2014-09-09 4 ASPX Auspex Pharmaceuticals, Inc.
Put Option (right to sell)
P - Purchase 1 1
2014-09-11 2014-09-09 4 ASPX Auspex Pharmaceuticals, Inc.
Put Option (right to sell)
P - Purchase 1 1
2014-09-11 2014-09-09 4 ASPX Auspex Pharmaceuticals, Inc.
Call Option (obligation to sell)
S - Sale -1 1 -50,00
2014-09-09 2014-09-03 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -312 96.108 -0,32 23,09 -7.205 2.219.499
2014-09-09 2014-09-03 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -12.188 3.746.249 -0,32 23,09 -281.467 86.515.125
2014-09-09 2014-09-02 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -255 96.420 -0,26 23,07 -5.883 2.224.352
2014-09-09 2014-09-02 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -9.945 3.758.437 -0,26 23,07 -229.425 86.704.887
2014-09-09 2014-08-29 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -217 96.675 -0,22 22,59 -4.903 2.184.101
2014-09-09 2014-08-29 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -8.483 3.768.382 -0,22 22,59 -191.650 85.136.040
2014-09-09 2014-08-28 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -305 96.892 -0,31 22,24 -6.784 2.155.033
2014-09-09 2014-08-28 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -11.895 3.776.865 -0,31 22,24 -264.564 84.003.521
2014-09-09 2014-08-27 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -435 97.197 -0,45 21,88 -9.517 2.126.408
2014-09-09 2014-08-27 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -16.965 3.788.760 -0,45 21,88 -371.148 82.887.839
2014-09-09 2014-08-26 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -157 97.632 -0,16 21,35 -3.352 2.084.629
2014-09-09 2014-08-26 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -6.143 3.805.725 -0,16 21,35 -131.165 81.259.460
2014-09-09 2014-08-25 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -135 97.789 -0,14 20,81 -2.809 2.034.706
2014-09-09 2014-08-25 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -5.265 3.811.868 -0,14 20,81 -109.549 79.313.919
2014-09-09 2014-08-22 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -42 97.924 -0,04 20,56 -863 2.013.131
2014-09-09 2014-08-22 4/A ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -1.658 3.817.133 -0,04 20,56 -34.085 78.473.002
2014-09-08 2014-09-05 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -222 95.469 -0,23 23,50 -5.217 2.243.445
2014-09-08 2014-09-05 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -8.678 3.721.288 -0,23 23,50 -203.926 87.447.291
2014-09-08 2014-09-04 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -417 95.691 -0,43 24,05 -10.030 2.301.531
2014-09-08 2014-09-04 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -16.283 3.729.966 -0,43 24,05 -391.634 89.712.023
2014-09-08 2014-05-16 4 ASPX Auspex Pharmaceuticals, Inc.
Warrant (right to buy)
X - Other 1.175 0 -100,00
2014-09-08 2014-05-16 4 ASPX Auspex Pharmaceuticals, Inc.
Warrant (right to buy)
X - Other 45.853 0 -100,00
2014-09-08 2014-05-16 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
X - Other 1.175 97.966 1,21 3,88 4.558 380.010
2014-09-08 2014-05-16 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
X - Other 45.853 3.818.791 1,22 3,88 177.864 14.813.090
2014-09-04 2014-09-03 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -312 94.933 -0,33 23,09 -7.205 2.192.364
2014-09-04 2014-09-03 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -12.188 3.700.396 -0,33 23,09 -281.467 85.456.205
2014-09-04 2014-09-02 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -255 95.245 -0,27 23,07 -5.883 2.197.245
2014-09-04 2014-09-02 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -9.945 3.712.584 -0,27 23,07 -229.425 85.647.085
2014-09-03 2014-08-29 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -217 95.500 -0,23 22,59 -4.903 2.157.555
2014-09-03 2014-08-29 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -8.483 3.722.529 -0,23 22,59 -191.650 84.100.120
2014-08-29 2014-08-28 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -305 95.717 -0,32 22,24 -6.784 2.128.899
2014-08-29 2014-08-28 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -11.895 3.731.012 -0,32 22,24 -264.564 82.983.676
2014-08-29 2014-08-27 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -435 96.022 -0,45 21,88 -9.517 2.100.702
2014-08-29 2014-08-27 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -16.965 3.742.907 -0,45 21,88 -371.148 81.884.699
2014-08-28 2014-08-26 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -157 96.457 -0,16 21,35 -3.352 2.059.540
2014-08-28 2014-08-26 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -6.143 3.759.872 -0,16 21,35 -131.165 80.280.411
2014-08-27 2014-08-25 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -135 96.614 -0,14 20,81 -2.809 2.010.257
2014-08-27 2014-08-25 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -5.265 3.766.015 -0,14 20,81 -109.549 78.359.851
2014-08-26 2014-08-22 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -42 96.749 -0,04 20,56 -863 1.988.976
2014-08-26 2014-08-22 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
S - Sale -1.658 3.771.280 -0,04 20,56 -34.085 77.530.351
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series A Preferred Stock
C - Conversion -21.989 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series A Preferred Stock
C - Conversion -857.595 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
C - Conversion -72.830 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
C - Conversion -2.840.466 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
J - Other -30 72.830 -0,04
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
J - Other -1.132 2.840.466 -0,04
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
X - Other 4.479 72.860 6,55
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
X - Other 175.882 2.841.598 6,60
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock Purchase Warrant
X - Other -1.127 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock Purchase Warrant
X - Other -3.382 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock Purchase Warrant
X - Other -43.970 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock Purchase Warrant
X - Other -131.912 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 7.921 102.740 8,35 14,00 110.894 1.438.360
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 21.989 94.819 30,19
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 72.830 72.830
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 308.905 4.006.966 8,35 14,00 4.324.670 56.097.524
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 857.595 3.698.061 30,19
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 2.840.466 2.840.466
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock Warrant
C - Conversion 64.449 64.449
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Preferred Stock Warrant
C - Conversion -290.022 0 -100,00
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock Warrant
C - Conversion 121.165 121.165
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Preferred Stock Warrant
C - Conversion -545.243 0 -100,00
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock Warrant
C - Conversion 42.340 42.340
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Preferred Stock Warrant
C - Conversion -190.535 0 -100,00
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock Warrant
C - Conversion 42.966 42.966
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Preferred Stock Warrant
C - Conversion -193.348 0 -100,00
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock Warrant
C - Conversion 47.028 47.028
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Preferred Stock Warrant
C - Conversion -211.629 0 -100,00
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Series E Convertible Preferred Stock
C - Conversion -1.397.873 0 -100,00
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Series D Convertible Preferred Stock
C - Conversion -8.510.898 0 -100,00
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Series C Convertible Preferred Stock
C - Conversion -5.394.437 0 -100,00
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
C - Conversion -1.635.551 0 -100,00
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 2.688 96.796 2,86 12,00 32.256 1.161.552
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
C - Conversion 94.103 94.103
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 102.873 3.772.938 2,80 12,00 1.234.476 45.275.256
2014-02-12 2014-02-10 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
C - Conversion 3.670.065 3.670.065
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)